Cytomab 500mg Injection

About

Cytomab 500mg Injection contains rituximab, a chimeric monoclonal antibody that specifically targets the CD20 antigen found on the surface of pre-B and mature B-lymphocytes. Upon binding, rituximab initiates a cascade of immune responses, including antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct induction of apoptosis, leading to the depletion of CD20-positive B cells. This mechanism makes it highly effective in treating various B-cell lymphomas, leukemias, and autoimmune diseases where B cells play a pathogenic role.

Its therapeutic action helps to reduce disease activity and improve patient outcomes by selectively removing abnormal or autoreactive B cells while sparing hematopoietic stem cells. This targeted approach minimizes damage to other cell types, making it a valuable treatment option for conditions requiring B-cell modulation.

Uses

• Treatment of non-Hodgkin's lymphoma (NHL).
• Treatment of chronic lymphocytic leukemia (CLL).
• Treatment of rheumatoid arthritis (RA) in combination with methotrexate.
• Treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).

Directions For Use

Administered as an intravenous infusion by a healthcare professional. Pre-medication is often required to reduce infusion-related reactions.

Benefits

• Effective in inducing remission in B-cell malignancies.
• Reduces disease activity and progression in autoimmune conditions.
• Can be used in combination with chemotherapy for enhanced efficacy.
• Improves quality of life for patients with severe autoimmune diseases.
• Well-established safety profile with extensive clinical experience.
• Targets specific immune cells, minimizing damage to other cell types.

Side Effects

• Infusion-related reactions (fever, chills, nausea)
• Progressive multifocal leukoencephalopathy (PML)
• Hepatitis B reactivation
• Infections (bacterial, viral, fungal)
• Leukopenia
• Thrombocytopenia
• Anemia
• Hypotension
• Pruritus
• Rash
• Fatigue
• Headache

Safety Measures

• Alcohol - No direct interaction with alcohol is known, but alcohol consumption should be discussed with a doctor, especially if liver function is compromised or other medications are taken.
• Pregnancy - Not recommended during pregnancy as it can cross the placenta and cause B-cell depletion in the fetus; use effective contraception during and for 12 months after treatment.
• Breastfeeding - Not recommended during breastfeeding as rituximab can be excreted in breast milk and may cause B-cell depletion in the infant.
• Liver - Use with caution in patients with a history of hepatitis B infection due to the risk of reactivation; screening is mandatory before treatment.
• Kidney - No specific dose adjustment is generally required for patients with renal impairment, but close monitoring is advised.
• Lung - Use with caution in patients with pre-existing lung conditions, as pulmonary adverse events, including interstitial lung disease, have been reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.